Krsnaa Diagnostics Limited (NSE:KRSNAA)
809.55
+0.40 (0.05%)
Aug 25, 2025, 9:30 AM IST
Krsnaa Diagnostics Revenue
Krsnaa Diagnostics had revenue of 1.93B INR in the quarter ending June 30, 2025, with 13.36% growth. This brings the company's revenue in the last twelve months to 7.40B, up 13.78% year-over-year. In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.17B with 15.74% growth.
Revenue (ttm)
7.40B
Revenue Growth
+13.78%
P/S Ratio
3.55
Revenue / Employee
n/a
Employees
3,700
Market Cap
26.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 7.17B | 975.27M | 15.74% |
Mar 31, 2024 | 6.20B | 1.33B | 27.20% |
Mar 31, 2023 | 4.87B | 316.73M | 6.95% |
Mar 31, 2022 | 4.55B | 589.94M | 14.88% |
Mar 31, 2021 | 3.96B | 1.38B | 53.41% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Krsnaa Diagnostics News
- 13 days ago - Krsnaa Diagnostics shares fall over 3% following Q1 results - Business Upturn
- 6 weeks ago - Krsnaa Diagnostics gets Rajasthan High Court nod, to proceed with NHM lab services contract - Business Upturn
- 4 months ago - Top stocks to buy today: Stock recommendations for April 23, 2025 - The Times of India
- 9 months ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 10 months ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn
- 11 months ago - Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi - Business Upturn
- 11 months ago - Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare - The Times of India
- 11 months ago - Krsnaa Diagnostics secures radiology services contract at Sadar Hospital, Ranchi - Business Upturn